George Dakwar | Director Formulation Platform
CureVac AG

Director Formulation Platform at CureVac SE Holds a PhD degree in Drug delivery and Nanomedicines from the Ghent University. Currently leading discovery formulation activities within CureVac (Tubingen, Germany). During his career, he focused on the delivery of multiple RNA modalities (e.g., siRNA, mRNA, saRNA) and worked in different industrial functions including discovery and CMC development of lipid nanoparticles (LNPs). Before joining CureVac, he served as an Associate Director at VaxEquity (Cambridge, UK) and a Senior Scientist Drug Product Development at eTheRNA Immunotherapies (Ghent, Belgium).